Prevalence of muscular dystrophies: A systematic literature review

Neuroepidemiology

Volumn 43, Issue 3-4, 2014, Pages 259-268

  Theadom, Alice ^a   Rodrigues, Miriam ^b,c   Roxburgh, Richard ^b   Balalla, Shiavnthi ^a   Higgins, Chris ^c   Bhattacharjee, Rohit ^a   Jones, Kelly ^a   Krishnamurthi, Rita ^a   Feigin, Valery ^a  

^a AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c Muscular Dystrophy Association of New Zealand   (New Zealand)

Author keywords

Epidemiology; Muscular dystrophy; Myotonic dystrophy; Prevalence; Systematic review

Indexed keywords

CANADA; CHINA; CROATIA; DUCHENNE MUSCULAR DYSTROPHY; EMERY DREIFUSS MUSCULAR DYSTROPHY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; HUMAN; ITALY; JAPAN; LIBYAN ARAB JAMAHIRIYA; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCULAR DYSTROPHY; MYOTONIC DYSTROPHY; NETHERLANDS; NEW ZEALAND; NORWAY; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PACIFIC ISLANDS; PORTUGAL; PREVALENCE; REVIEW; RUSSIAN FEDERATION; SLOVENIA; SOUTH AFRICA; SPAIN; SWEDEN; TAIWAN; UNITED KINGDOM; UNITED STATES; CROSS-SECTIONAL STUDY; FEMALE; MALE; MUSCULAR DYSTROPHIES; STATISTICAL BIAS;

BIAS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MUSCULAR DYSTROPHIES; PREVALENCE;

EID: 84919999227     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000369343     Document Type: Review

References (57)

1. Mercuri E, Muntoni F: Muscular dystrophies. Lancet 2013; 381: 845-860.
2. McNally EM, Pytel P: Muscle diseases: the muscular dystrophies. Annu Rev Pathol 2007; 2: 87-109.
3. Mercuri E, Muntoni F: Muscular dystrophy: new challenges and review of the current clinical trials. Curr Opin Pediatr 2013; 25: 701-707.
4. Turner C, Hilton-Jones D: The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry 2010; 81: 358-367.
5. Graham CD, Rose MR, Grunfeld EA, Kyle SD, Weinman J: A systematic review of quality of life in adults with muscle disease. J Neurol 2011; 258: 1581-1592.
6. Boyer F, Drame M, Morrone I, Novella JL: Factors relating to carer burden for families of persons with muscular dystrophy. J Rehabil Med 2006; 38: 309-315.
7. Emery AE: Muscular dystrophy into the new millennium. Neuromuscul Disord 2002; 12: 343-349.
8. Fiest KM, Pringsheim T, Patten SB, Svenson LW, Jette N: The role of systematic reviews and meta-analyses of incidence and prevalence studies in neuroepidemiology. Neuroepidemiology 2014; 42: 16-24.
9. Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N: A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 2014; 24: 482-491.
10. Lemmers RJ, O'Shea S, Padberg GW, Lunt PW, van der Maarel SM: Best practice guidelines on genetic diagnostics of Facioscapulohumeral muscular dystrophy: workshop 9th June 2010, LUMC, Leiden, The Netherlands. Neuromuscul Disord 2012; 22: 463-470.
11. Tawil R, van der Maarel S, Padberg GW, van Engelen BG: 171st ENMC international workshop: standards of care and management of facioscapulohumeral muscular dystrophy. Neuromuscul Disord 2010; 20: 471-475.
12. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, Mc-Donald C, Pandya S, et al: Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010; 9: 77-93.
13. Wang CH, Bonnemann CG, Rutkowski A, Sejersen T, Bellini J, Battista V, Florence JM, Schara U, Schuler PM, Wahbi K, et al: Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol 2010; 25: 1559-1581.
14. Turner C, Hilton-Jones D, Lochmüller H, Hanna MG: MRC Centre for Neuromuscular Diseases 1st (1st December 2010), and 2nd (2nd May 2012) myotonic dystrophy workshops, London, UK and the myotonic dystrophy standards of care and national registry meeting, Newcastle, UK July 2011. Neuromuscul Disord 2013; 23: 1069-1080.
15. Mayr E: Systematics and the Origin of Species from the Viewpoint of a Zoologist, vol 237. New York, Columbia University, 1942.
16. Bertolotto A, De Marchi M, Doriguzzi C, Mongini T, Monnier C, Palmucci L, Schiffer D, Verzé L: Epidemiology of Duchenne muscular dystrophy in the province of Turin. Ital J Neurol Sci 1981; 2: 81-84.
17. Danieli GA, Mostacciuolo ML, Bonfante A, Angelini C: Duchenne muscular dystrophy. A population study. Hum Genet 1977; 35: 225-231.
18. Fanin M, Nascimbeni AC, Fulizio L, Angelini C: The frequency of limb girdle muscular dystrophy 2A in northeastern Italy. Neuromuscul Disord 2005; 15: 218-224.
19. Merlini L, Stagni SB, Marri E, Granata C: Epidemiology of neuromuscular disorders in the under-20 population in Bologna Province, Italy. Neuromuscul Disord 1992; 2: 197-200.
20. Mostacciuolo ML, Pastorello E, Vazza G, Miorin M, Angelini C, Tomelleri G, Galluzzi G, Trevisan CP: Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample. Clin Genet 2009; 75: 550-555.
21. Mostacciuolo ML, Miorin M, Martinello F, Angelini C, Perini P, Trevisan CP: Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy. Hum Genet 1996; 97: 277-279.
22. Mostacciuolo ML, Lombardi A, Cambissa V, Danieli GA, Angelini C: Population data on benign and severe forms of X-linked muscular dystrophy. Hum Genet 1987; 75: 217-220.
23. Pinessi L, Bergamini L, Cantello R, Di Tizio C: Myotonia congenita and myotonic dystrophy: descriptive epidemiological investigation in Turin, Italy (1955-1979). Ital J Neurol Sci 1982; 3: 207-210.
24. Siciliano G, Manca M, Gennarelli M, Angelini C, Rocchi A, Iudice A, Miorin M, Mostacciuolo M: Epidemiology of myotonic dystrophy in Italy: re-appraisal after genetic diagnosis. Clin Genet 2001; 59: 344-349.
25. Sposito R, Pasquali L, Galluzzi F, Rocchi A, Solito B, Soragna D, Tupler R, Siciliano G: Facioscapulohumeral muscular dystrophy type 1A in northwestern Tuscany: a molecular genetics-based epidemiological and genotypephenotype study. Genet Test 2005; 9: 30-36.
26. Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V: Prevalence of genetic muscle disease in Northern England: indepth analysis of a muscle clinic population. Brain 2009; 132: 3175-3186.
27. MacMillan JC, Harper PS: Single-gene neurological disorders in South Wales: an epidemiological study. Ann Neurol 1991; 30: 411-414.
28. Bushby KM, Thambyayah M, Gardner-Medwin D: Prevalence and incidence of Becker muscular dystrophy. Lancet 1991; 337: 1022-1024.
29. Yates JR, Emery AE: A population study of adult onset limb-girdle muscular dystrophy. J Med Genet 1985; 22: 250-257.
30. Magee A, Nevin NC: The epidemiology of myotonic dystrophy in Northern Ireland. Community Genet 1999; 2: 179-183.
31. McKeever K, Magee A: Epidemiology and genetics of Duchenne muscular dystrophy in Northern Ireland. Am J Hum Genet 2003; 73: 373.
32. Hughes MI, Hicks EM, Nevin NC, Patterson VH: The prevalence of inherited neuromuscular disease in Northern Ireland. Neuromuscul Disord 1996; 6: 69-73.
33. Okinaka S, Reese HH, Katsuki S, Ueki K, Kuroiwa Y, Araki S, Shiraki H, Kurland LT: The prevalence of multiple sclerosis and other neurological diseases in Japan. Acta Neurol Scand 1966; 42: 68-76.
34. Nakagawa M, Nakahara K, Yoshidome H, Suehara M, Higuchi I, Fujiyama J, Nakamura A, Kubota R, Takenaga S, Arahata K, et al: Epidemiology of progressive muscular dystrophy in Okinawa, Japan. Classification with molecular biological techniques. Neuroepidemiology 1991; 10: 185-191.
35. Araki S, Uchino M, Kumamoto T: Prevalence studies of multiple sclerosis, myasthenia gravis, and myopathies in Kumamoto district, Japan. Neuroepidemiology 1987; 6: 120-129.
36. Ahlström G, Gunnarsson LG, Leissner P, Sjödén PO: Epidemiology of neuromuscular diseases, including the postpolio sequelae, in a Swedish county. Neuroepidemiology 1993; 12: 262-269.
37. Darin N, Tulinius M: Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden. Neuromuscul Disord 2000; 10: 1-9.
38. Mah JK, Selby K, Campbell C, Nadeau A, Tarnopolsky M, McCormick A, Dooley JM, Kolski H, Skalsky AJ, Smith RG, et al: A population-based study of dystrophin mutations in Canada. Can J Neurol Sci 2011; 38: 465-474.
39. Monckton G, Hoskin V, Warren S: Prevalence and incidence of muscular dystrophy in Alberta, Canada. Clin Genet 1982; 21: 19-24.
40. Chung B, Wong V, Ip P: Prevalence of neuromuscular diseases in Chinese children: a study in southern China. J Child Neurol 2003; 18: 217-219.
41. Medica I, Markovi D, Peterlin B: Genetic epidemiology of myotonic dystrophy in Istria, Croatia. Acta Neurol Scand 1997; 95: 164-166.
42. El-Tallawy HN, Khedr EM, Qayed MH, Helliwell TR, Kamel NF: Epidemiological study of muscular disorders in Assiut, Egypt. Neuroepidemiology 2005; 25: 205-211.
43. Radhakrishnan K, El-Mangoush MA, Gerryo SE: Descriptive epidemiology of selected neuromuscular disorders in Benghazi, Libya. Acta Neurol Scand 1987; 75: 95-100.
44. van der Kooi AJ, Barth PG, Busch HF, de Haan R, Ginjaar HB, van Essen AJ, van Hooff LJ, Höweler CJ, Jennekens FG, Jongen P, et al: The clinical spectrum of limb girdle muscular dystrophy. A survey in The Netherlands. Brain 1996; 119: 1471-1480.
45. Ford C, Kidd A, Hammond-Tooke G: Myotonic dystrophy in Otago, New Zealand. N Z Med J 2006; 119:U2145.
46. Tangsrud SE, Halvorsen S: Child neuromuscular disease in southern Norway. Prevalence, age and distribution of diagnosis with special reference to 'non-Duchenne muscular dystrophy'. Clin Genet 1988; 34: 145-152.
47. Santos MA, Fineza I, Moreno T, Cabral P, Ferreira JC, Silva RL, Vieira JP, Moreira A, Dias A, Calado E, et al: Epidemiology of neuromuscular disorders in Portugal at pediatric age. Neuromuscul Disord 2006; 16: 703.
48. Krivopusk ME: The clinico-epidemiological aspects of hereditary neuromuscular diseases in the Krasnodar territory. Zh Nevropatol Psikhiatr Im S S Korsakova 1991; 91: 3-5.
49. Peterlin B, Zidar J, Meznaric-Petrusa M, Zupancic N: Genetic epidemiology of Duchenne and Becker muscular dystrophy in Slovenia. Clin Genet 1997; 51: 94-97.
50. Ballo R, Viljoen D, Beighton P: Duchenne and Becker muscular dystrophy prevalence in South Africa and molecular findings in 128 persons affected. S Afr Med J 1994; 84: 494-497.
51. Burcet J, Canellas F, Cavaller G, Vich M: Epidemiologic study of myotonic dystrophy on the island of Mallorca. Neurologia 1992; 7: 61-64.
52. Hsiao KM, Chen SS, Li SY, Chiang SY, Lin HM, Pan H, Huang CC, Kuo HC, Jou SB, Su CC, et al: Epidemiological and genetic studies of myotonic dystrophy type 1 in Taiwan. Neuroepidemiology 2003; 22: 283-289.
53. Kurtzke JF: Neuroepidemiology. Ann Neurol 1984; 16: 265-277.
54. Siciliano G, Tessa A, Renna M, Manca ML, Mancuso M, Murri L: Epidemiology of dystrophinopathies in North-West Tuscany: a molecular genetics-based revisitation. Clin Genet 1999; 56: 51-58.
55. Wade BJ: Spatial analysis of global prevalence of multiple sclerosis suggests need for an updated prevalence scale. Mult Scler Int 2014; 2014: 124578.
56. Ruano L, Melo C, Silva MC, Coutinho P: The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 2014; 42: 174-183.
57. Ahlstrom G, Gunnarsson LG, Leissner P, Sjoden PO: Epidemiology of neuromuscular diseases, including the postpolio sequelae, in a Swedish county. Neuroepidemiology 1993; 12: 262-269.